Michael J. Gonzalez, PhD provides a deep dive into the use of vitamin C in patients with COVID-19. He describes vitamin C as a modulator that is capable of different actions depending on the environment and provides suggestions on best practices for use. He suggests mortality related to COVID-19 may be related to nutrient deficiencies and highlights the importance of diet as part of a plan to support immune resilience.
Michael J. Gonzalez, PhD is a Professor at the Nutrition Program, School of Public Health in the Medical Sciences Campus, University of Puerto Rico and Adjunct faculty at the Universidad Central del Caribe. Dr. Gonzalez is a Fellow of the American College of Nutrition and has authored over 250 scientific publications. He has also been a consultant for The Center for the Improvement of Human Functioning (now Riordan Clinic), in Wichita, Kansas and the Centro Medico Regenerativo in Bayamon, Puerto Rico. He has obtained several research awards for his work on nutrition, supplementation, and cancer. He is currently Director of RECNAC II project and Research Director of the InBioMed Project Initiative. He is in a part-time clinical practice in Ponce, PR. In December 2013, Dr. Gonzalez was exalted as Distinguished Ponceño in the area of Medicine, due to his contributions in various areas of nontoxic disease therapy. In 2015 he was selected as member to the prestigious Puerto Rican Academy of Arts and Sciences and to the Iberoamerican Academy of Culture and Sciences.
Doctor González is a founder of InBioMed, leader in the development of nontoxic chemotherapy treatments for cancer. The findings of the team’s work with intravenous vitamin C as an anticancer agent, published in 2002, were confirmed by the NIH in 2005. They published the first Phase-I clinical study utilizing Intravenous Vitamin C for treatment of terminal cancer patients in 2005, and also published in 2005 the most comprehensive review on vitamin C and cancer, as a follow-up on the work of two-time Nobel Laureate Dr. Linus C. Pauling. Dr. Gonzalez was inducted to the International Hall of fame of Orthomolecular Medicine in 2016.